Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Chetna Desai"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 2, Pp WC10-WC13 (2023)
Introduction: Severe Cutaneous Adverse Reactions (SCADRs) are emergency dermatologic manifestations associated with high morbidity and mortality. Their management includes immediate withdrawal of suspected causal agent followed by prompt management w
Externí odkaz:
https://doaj.org/article/47dd1d6b9d314b948d1404043abb749c
Autor:
Chetna Desai
Publikováno v:
Research and Humanities in Medical Education, Vol 9, Pp 24-26 (2022)
Externí odkaz:
https://doaj.org/article/86bf070a52564affa67e8e7adbd0117e
Publikováno v:
Perspectives in Clinical Research, Vol 9, Iss 1, Pp 15-22 (2018)
Aims: This study aims to measure the quality of life (QOL), treatment satisfaction, and tolerability of antidiabetic drugs in patients suffering from type 2 diabetes mellitus (DM). Methods: The prospective, observational study was conducted in consen
Externí odkaz:
https://doaj.org/article/f0fca6d8b7e54145b65b57dc8029f4d9
Autor:
Chetna Desai
Publikováno v:
Perspectives in Clinical Research, Vol 9, Iss 2, Pp 108-109 (2018)
Externí odkaz:
https://doaj.org/article/b191332efd8d4d6eaba89d1a4afe57f4
Autor:
Mansi Pandya, Chetna Desai
Publikováno v:
Perspectives in Clinical Research, Vol 4, Iss 1, Pp 70-74 (2013)
Externí odkaz:
https://doaj.org/article/d578aa1aa5b84e56997fdf4749c1531c
Autor:
Jaya Ranjalkar, Ratinder Jhaj, Sujith J Chandy, Heber R Bright, Preeta K Chugh, Chakra D Tripathi, Dinesh K Badyal, Sadasivam Balakrishnan, Bikash Medhi, Sandhya K Kamat, Raakhi Tripathi, Harihar Dikshit, Sukalyan S Roy, Suparna Chatterjee, Manjari Bhattacharjee, Niyati Trivedi, Chetna Desai, Pooja Gupta, Atanu Roy, Ramasamy Raveendran, Jayanthi Mathaiyan, Sandeep Kaushal, Samriti Jain, Rajni Kaul, Nilima A Kshirsagar
Publikováno v:
Journal of The Association of Physicians of India. 71:30-36
Aim: Irrational use of medicines is a global problem. In India, one contributing factor is the availability of a large number of fixed-dose combinations (FDCs). To improve rational use and to strengthen policies, it is important to assess the usage p
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :88-91
Objectives: The aim of the study was to evaluate the adverse drug reactions (ADR) following Remdesivir therapy in patients of COVID-19. Methods: All patients more than 18 years of age of any gender, diagnosed with COVID-19 infection receiving remdesi
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :38-41
BACKGROUND:Chronic disease and life threatening disorders among CCU patients have resulted in medicating them with drugs from different pharmacological classes, which is further complicated by the altered physiology and multi-organ system failure. OB